NImmune Biopharma
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis (NCT04835168) | NImmune Biopharma | 2022-01-30 |
| Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease (NCT05057273) | NImmune Biopharma | 2021-11-01 |
| Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers (NCT05019950) | NImmune Biopharma | 2021-10-28 |
| Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease (NCT03870334) | NImmune Biopharma | 2021-05-05 |
| Efficacy and Safety of Oral BT-11 in Ulcerative Colitis (NCT03861143) | NImmune Biopharma | 2019-08-14 |
| Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers (NCT03860571) | NImmune Biopharma | 2018-07-06 |
Track NImmune Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.